Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Open Access

Correction

Correction: Urine peptidome in combination with transcriptomics analysis highlights MMP7, MMP14 and PCSK5 for further investigation in chronic kidney disease

  • The PLOS ONE Staff
  • Article
  • Metrics
  • Comments
  • Media Coverage

Notice of Republication

This article was republished on June 5, 2024, to correct for column and line duplication in Table 3 introduced during the typesetting process. Please download this article again to view the correct version.

Supporting information

S1 File. Originally published, uncorrected article.

https://doi.org/10.1371/journal.pone.0305767.s001

(PDF)

S2 File. Republished, corrected article.

https://doi.org/10.1371/journal.pone.0305767.s002

(PDF)

Reference

  1. 1. Petra E, Siwy J, Vlahou A, Jankowski J (2022) Urine peptidome in combination with transcriptomics analysis highlights MMP7, MMP14 and PCSK5 for further investigation in chronic kidney disease. PLoS ONE 17(1): e0262667. https://doi.org/10.1371/journal.pone.0262667 pmid:35045102

Citation: The PLOS ONE Staff (2024) Correction: Urine peptidome in combination with transcriptomics analysis highlights MMP7, MMP14 and PCSK5 for further investigation in chronic kidney disease. PLoS ONE 19(6): e0305767. https://doi.org/10.1371/journal.pone.0305767

Published: June 13, 2024

Copyright: © 2024 The PLOS ONE Staff. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.